U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06919107) titled 'Advanced Footwear Technology in Federated Athletes' on March 25. Brief Summary: Backgroun... Read More
U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06918678) titled 'Feasibility and Efficacy of A Remote Tai Chi Program in Older Adults' on March 21. Brief ... Read More
U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06917807) titled 'Pain Relief Comparison: Pericapsular Nerve Group Versus Quadratus Lumborum Block for Posit... Read More
U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06918028) titled 'An Interpretable Fundus Diseases Report Generating System Based On Weakly Labelings' on Ma... Read More
U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06919887) titled 'A Randomized Controlled Trial of Menopausal Tool/App for Women' on March 25. Brief Summar... Read More
U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06918197) titled 'Evaluation the Impact of the "Pas" Technique Versus the "Standard" Technique on Radiation ... Read More
U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06919783) titled 'Adapting a Health at Every Size Intervention to Obstetric Care' on April 02. Brief Summar... Read More
U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06919861) titled 'The Pharmacokinetics, Pharmacodynamics, and Safety of Nanokine Produced by Nanogen Pharmac... Read More
U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06919328) titled 'Absorption and Tolerability of Injectable Administration of Niagen(R)+, as Compared to NAD... Read More
U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06917911) titled 'Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regime... Read More